EuroIntervention | Editor's Choice
In this episode of Editor’s Choice, Dr Aaysha Cader speaks with Dr Juan Miguel Ruiz-Nodar about the results of the GLUCO-TAVI trial, recently published in EuroIntervention. They discuss the impact of glucocorticoid therapy on reducing permanent pacemaker implantation (PPI) following TAVI, highlighting a 50% relative risk reduction at one month. Dr Ruiz-Nodar also shares insights into the mechanisms behind these findings and outlines plans for a larger randomised trial to confirm the results and define optimal dosing and treatment duration. ---------------------------------------- Hosted on Acast. See acast.com/privacy [https://acast.com/privacy] for more information.
6 Folgen
Kommentare
0Sei die erste Person, die kommentiert
Melde dich jetzt an und werde Teil der EuroIntervention | Editor's Choice-Community!